150 related articles for article (PubMed ID: 35654114)
1. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
[TBL] [Abstract][Full Text] [Related]
2. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
[TBL] [Abstract][Full Text] [Related]
3. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
4. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
[TBL] [Abstract][Full Text] [Related]
5. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance.
Sánchez V; Brandt A; Jin CJ; Rajcic D; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809593
[TBL] [Abstract][Full Text] [Related]
6. Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice.
Sánchez V; Baumann A; Brandt A; Wodak MF; Staltner R; Bergheim I
Cell Mol Gastroenterol Hepatol; 2024; 17(5):785-800. PubMed ID: 38262589
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
9. Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.
Brandt A; Rajcic D; Jin CJ; Sánchez V; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
Metabolism; 2020 Aug; 109():154283. PubMed ID: 32497536
[TBL] [Abstract][Full Text] [Related]
10. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.
Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I
J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046
[TBL] [Abstract][Full Text] [Related]
11. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
Brandt A; Hernández-Arriaga A; Kehm R; Sánchez V; Jin CJ; Nier A; Baumann A; Camarinha-Silva A; Bergheim I
Sci Rep; 2019 Apr; 9(1):6668. PubMed ID: 31040374
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
14. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
15. Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice.
Tiyerili V; Becher UM; Camara B; Yildirimtürk C; Aksoy A; Kebschull M; Werner N; Nickenig G; Müller C
Arch Med Sci; 2015 Aug; 11(4):877-85. PubMed ID: 26322101
[TBL] [Abstract][Full Text] [Related]
16. The Peroxisome Proliferator-Activated Receptor (PPAR)-
Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
[TBL] [Abstract][Full Text] [Related]
17. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
18. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.
Baumann A; Rajcic D; Brandt A; Sánchez V; Jung F; Staltner R; Nier A; Trauner M; Staufer K; Bergheim I
J Cell Mol Med; 2022 Feb; 26(4):1206-1218. PubMed ID: 35029027
[TBL] [Abstract][Full Text] [Related]
19. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
20. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase.
Rajcic D; Baumann A; Hernández-Arriaga A; Brandt A; Nier A; Jin CJ; Sánchez V; Jung F; Camarinha-Silva A; Bergheim I
Redox Biol; 2021 May; 41():101879. PubMed ID: 33550112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
